NSE · ASTERDM · Healthcare
Aster DM Healthcare Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹655 Cr with net profit ₹27 Cr — a 4.19% net margin, versus 8.29% the period before.
Shareholding
As of 2026-07-31
- Promoter53.72%
- Public19.49%
- FII10.31%
- DII16.48%
1,33,338 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.63× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
AI analysis
AI-generated · google/gemini-2.5-flashAster DM Healthcare Ltd. recorded total revenue of Rs 4286.69 Cr. The company has a market capitalization of Rs 70906 Cr. The company's EPS stands at 124.3, with a Price-to-Earnings ratio of 3.9. Return on equity (ROE) is 214.9%, and Return on capital employed (ROCE) is 10.09%.
Positives
- +The Return on Equity (ROE) is 214.9%, indicating high profitability in relation to shareholder equity.
- +The Return on Capital Employed (ROCE) is 10.09%, reflecting efficient use of capital.
- +The Price-to-Earnings (PE) ratio is 3.9, which could indicate a relatively low valuation compared to earnings.
- +The debt-to-equity ratio is 0.31, indicating relatively low financial leverage.
Negatives
- −Promoter holding of 40.39% is below 50% as of June 30, 2026.
- −Promoter pledge stands at 40.66% of promoter shareholding as of June 30, 2026.
- −Net profit in the annual results declined from Rs 61.07 Cr in Mar 2025 to Rs 27.46 Cr in Mar 2026.
Financial Performance
In the annual periods reported, revenue was Rs 573.86 Cr in Mar 2025, Rs 613.04 Cr in Jun 2025, Rs 681.81 Cr in Sept 2025, Rs 665.75 Cr in Dec 2025, and Rs 655.1 Cr in Mar 2026. Net profit fluctuated, from Rs 61.07 Cr in Mar 2025 to Rs 27.46 Cr in Mar 2026. Quarterly revenue shows a trend; Rs 1049.81 Cr in Dec 2024, Rs 1000.34 Cr in Mar 2025, Rs 1077.87 Cr in Jun 2025, Rs 1197.21 Cr in Sept 2025, Rs 1185.76 Cr in Dec 2025, and Rs 1182.38 Cr in Mar 2026.
Profitability & Returns
The company reported a Return on Equity (ROE) of 214.9% and a Return on Capital Employed (ROCE) of 10.09%. The Earnings Per Share (EPS) is 124.3. The Price-to-Earnings (PE) ratio is 3.9.
Balance Sheet
The company maintains a debt-to-equity ratio of 0.31, indicating a reliance on equity financing. The book value per share is Rs 58.28.
Ownership & Pledges
As of June 30, 2026, promoter holding stands at 40.39%. Public shareholding is 21.42%. Total institutional holding is 38.18%. A significant portion of promoter shares, 40.66%, are pledged. Specifically, Union Investments Private Limited has pledged 65,116,298 shares (34.85% of its holding) and Union (Mauritius) Holdings Limited has pledged 19,980,522 shares (100% of its holding) as of June 30, 2026.
Regulatory & Surveillance
The company is not currently under any regulatory or surveillance measures in the provided data.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jul 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.